Atlas Trials

High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma

Clinical trial NCT02531841 · UNKNOWN

Trial details

NCT number
NCT02531841
Sponsor
University Hospital Freiburg
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Diffuse Large B-cell-lymphoma
Start date
2014-07-01
Primary completion
2017-11-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.